产品名称 | NebuSelect™ Recombinant Mouse BACE-1, His-tag |
---|---|
目录号 | NBL-243065 |
别名 | BACE-1; Beta-secretase 1; ASP2; Asp 2; BACE1; BACE; FLJ90568; HSPC104; KIAA1149; Memapsin-2; BACE-1; EC 3.4.23; EC 3.4.23.46 |
外观 | see COA |
分子量 | Thr22-Thr457 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | P56818 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-243065-100ug | 100ug | Inquire | Inquire | |
NBL-243065-1mg | 1mg | Inquire | Inquire | |
NBL-243065-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Mouse BACE-1, His-tag
Catalog#:
NBL-243065
Description:
NebuSelect™ Recombinant Mouse BACE-1, His-tag(Cat#NBL-243065) is expressed in HEK293 with His tag at the C-Terminus.It contains Thr22-Thr457.
Species:
Mouse
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 49.49 kDa. Due to glycosylation, the protein migrates to 60-70 kDa based on Bis-Tris PAGE result.
Target Name:
BACE-1; Beta-secretase 1; ASP2; Asp 2; BACE1; BACE; FLJ90568; HSPC104; KIAA1149; Memapsin-2; BACE-1; EC 3.4.23; EC 3.4.23.46
Target Information:
The beta-site amyloid precursor protein cleaving enzyme-1 (BACE-1) initiates the generation of amyloid-β (Aβ), and the amyloid cascade leading to amyloid plaque deposition, neurodegeneration, and dementia in Alzheimer's disease (AD). Clinical failures of anti-Aβ therapies in dementia stages suggest that treatment has to start in the early, asymptomatic disease states.
Amino Acid Sequence:
Thr22-Thr457
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.